| Application no. and date | 16719356.4 (espacenet) (Federated) (European Patent Register), 20160420 | | Patent/reg. no. and date | DK/EP 3285772, 20191002 | | Publication date | 20180228 | | Priority no. and date | GB 201506786, 20150421 | | EP pub. no. and date |
EP 3285772 20180228 | | Effective date | | | Applicant/owner | UCB Biopharma SRL, 60, Allee de la Recherche
1070 Brussels, BE | | Applicant ref. no. | 163155 | | Inventor | ALLEN, Rodger Anthony, c/o IPD
UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
BARONE, Francesca, Rheumatology Research Group
Institute of Inflammation and Ageing (IIA)
University of Birmingham
Queen Elizabeth Hospital
Birmingham B15 2WB, GB,
FAHY, William Anthony, c/o IPD
UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
NAYAR, Saba, Rheumatology Research Group
Institute of Inflammation and Ageing (IIA)
University of Birmingham
Queen Elizabeth Hospital
Birmingham B15 2WB, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 37/00 (2006.01) | | Title | EN SPECIFIK TRIFLUORETHYLQUINOLINANALOG TIL ANVENDELSE VED BEHANDLINGEN AF SJÖGRENS SYNDROM | | Int. application no. | EP2016058810 | | Int. publication no. | WO2016170014 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
